Predicting recurrence of non-muscle-invasive XXXX after transurethral resection.

@entity1 @entity150 @entity5
UNASSIGNED: Aim To determine clinical prognostic factors and their impact on the risk of recurrence of newly discovered non-muscle-invasive @entity150 . Methods The study included 120 @entity1 of both sexes aged 45-80 years with newly discovered non-muscle-invasive @entity150 . All the @entity1 were treated surgically by transurethral electro resection (TUER). The outcome of @entity1 with and without recurrence was followed at intervals of three months after surgery, the total of two years. For monitoring the probability of early recurrence the criteria of the European Organization for Research and Treatment of @entity5 (EORTC) were used. Results The average age of the @entity1 was 65.9 years, 79 (79.2%) males and 21 (20.8%) females. The total of 67 (55.8%) @entity1 had a recurrence during the period of monitoring. The average time to the first and fourth recurrence was 15.4 and 23.9 months, respectively. Numbers of @entity5 and a degree of invasion had a significant prognostic impact on the risk of recurrence. The EORTC score was a highly significant predictor of recurrence (OR=1.237; p < 0.001). Conclusion Based on available clinical and pathological prognostic factors and by stratification of @entity1 into three disease risk groups it is possible to predict the possibility of disease. Individual approach and recommendations for the treatment using EORTC risk tables should improve the quality of treatment.
